期刊文献+

硫辛酸胶囊治疗糖尿病周围神经病变的疗效观察

下载PDF
导出
摘要 目的:探讨硫辛酸胶囊治疗糖尿病周围神经病变的疗效。方法:选择糖尿病周围神经病变患者217例,随机分为治疗组108例和对照组109例。试验组给予硫辛酸胶囊2粒,300mg/粒,1次/日,于早餐前0.5小时空腹口服;对照组给予甲钴胺片1片,0.5mg/片,3次/日,3餐前0.5小时空腹口服。疗程12周。分别观察治疗前后自觉症状和周围神经机能临床变化。结果:自觉症状总有效率,治疗组76.0%、对照组58.5%;两个数据集治疗组的有效率均高于甲钴胺组(P<0.05)。用药12周后周围神经机能临床检查变化比较,试验组变化均值6.88,对照组变化均值5.77,试验酸组和对照组差别无统计学意义;硫辛酸胶囊对肝肾功能、血脂、血白细胞和红细胞等实验室检查无显著影响,无严重不良事件发生,患者的不良反应较轻,能够耐受。结论:硫辛酸胶囊是治疗糖尿病周围神经并发症安全而有效的药物,具有良好的临床应用前景。
出处 《中国社区医师(医学专业)》 2012年第32期63-64,共2页
  • 相关文献

参考文献6

  • 1Thomas Konrad MD. a - Lipoic Acid Treat- ment Decreases Serum Lactate and Pyruvate Concentraitians and improves Glucose Effec- tiveness in lean and Obsess Patients with Type 2 Diabetes [ J 3. Diabetes Care, 1999,22 : 280 - 287.
  • 2A lexander S. ametov, MD : The Sensory Syme ptoms Of Diabetic Polyneuropathy Are Im- I:roved With - Lipoic Acid [ J ]. Diabetes Care,2003,26:770 - 776.
  • 3Antonio Ceriello. Md : New Insights On Oxida- tive Stress And Diabetic Complications May Lead To A "Causal" Antioxidant Therapy [ J ]. Diabetes Care ,2003,26 : 1589 - 1596.
  • 4Dan Ziegler, MD. FRCPE. Oral Treatment With - Lipoic Acid Improves Symptomatic Di- abetic Polyneuropathy [ J ]. Diabetes Care, 2006,29:2365 - 2370.
  • 5张蜀平,陆菊明,潘长玉,窦京涛,尹岭.弥可保对糖尿病周围神经病变治疗作用的实验研究[J].中华内分泌代谢杂志,1998,14(2):130-132. 被引量:167
  • 6刘国良,张海燕,曹翠平.α-硫辛酸(奥力宝)与糖尿病未梢神经病变[J].辽宁实用糖尿病杂志,2004,12(6):54-58. 被引量:18

二级参考文献53

  • 1窦京涛,李江源,汪寅章,黄兆坚.人绒毛膜促性腺激素对大鼠睾丸相关激素受体的影响[J].中华医学杂志,1994,74(9):570-571. 被引量:7
  • 2[1]Wolz P, Krieglstein J: Neuroprotective activity of lipoic and dihydrolipoic acid. In: Fuchs J, Packer L, Zimmer G, eds.Lipoic Acid in Health and Disease. New York: Marcel Dekker1997:205 - 225.
  • 3[2]Randie PJ: Regulatory interactions between lipids and carbohydrates:The glucose fatty acid cycle after 35 years. Diabetes Metab Rev 1998; 14:263 - 283.
  • 4[3]Betteridge DJ: What is oxidative stress? Metabolism 2000;49:3 - 8.
  • 5[4]Haffner SM: Clinical relevance of the oxidative stress concipt. Metabolism 2000; 49: 30 - 34.
  • 6[5]Christen Y:Oxidative stress and Alzheimer disease. Am J Clin Nutr 2000;71:621S-629S.
  • 7[6]Hartnett ME, Stratton RD, Browne RW, Rosner BA, Lanham RJ, Armstrong D: Serum markers for oxidative stress and severity of diabetic retnopathy. Diabetes Care 2000; 23: 234 -240.
  • 8[7]Ceriello A: Oxidative stress and glycemic regulation.Metabolism 2000; 49: 27 - 29.
  • 9[8]Wollheim CB: Beta-cell mitochondria in the regulation of insulin secretion: a new culprit in type Ⅱ diabetes. Diabetologia 2000 ;43 : 265 - 277.
  • 10[9]Fonseca V, Rosenstock J, Patwardhan R, Salzman A: Effect of metformin and rosiglitzzone combination therapy in patients with type 2 diabetes mellitus:A randomized controlled trial. J Am Med Assoc 2000;283:1695- 1702 .

共引文献183

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部